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To further our understanding of the association between self-reported childhood learning
disabilities (LDs) and atypical dementia phenotypes (Atypical Dementia), including logope-
nic primary progressive aphasia (L-PPA), Posterior Cortical Atrophy (PCA), and Dysexecu-
tive-type Alzheimer’s Disease (AD).
Methods
This retrospective case series analysis of 678 comprehensive neuropsychological assess-
ments compared rates of self-reported LD between dementia patients diagnosed with Typi-
cal AD and those diagnosed with Atypical Dementia. 105 cases with neuroimaging or CSF
data available and at least one neurology follow-up were identified as having been diag-
nosed by the neuropsychologist with any form of neurodegenerative dementia. These
cases were subject to a consensus diagnostic process among three dementia experts
using validated clinical criteria for AD and PPA. LD was considered Probable if two or more
statements consistent with prior LD were documented within the Social & Developmental
History of the initial neuropsychological evaluation.
Results
85 subjects (Typical AD n=68, Atypical AD n=17) were included in the final analysis. In
logistic regression models adjusted for age, gender, handedness, education and symptom
duration, patients with Probable LD, compared to patients without Probable LD, were signifi-
cantly more likely to be diagnosed with Atypical Dementia vs. Typical AD (OR 13.1, 95% CI
1.3-128.4). All three of the L-PPA cases reporting a childhood LD endorsed childhood
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difficulty with language. By contrast, both PCA cases reporting Probable childhood LD
endorsed difficulty with attention and/or math.
Conclusions
In people who develop dementia, childhood LD may predispose to atypical phenotypes.
Future studies are required to confirm whether atypical neurodevelopment predisposes to
regional-specific neuropathology in AD and other dementias.
Introduction
Adults with a childhood history of specific learning disabilities (LDs) may be more likely to
develop atypical phenotypes of dementia, including atypical Alzheimer’s Disease (AD) [1–3].
Typical AD begins with memory symptoms at onset which correlate well with tau pathology in
the hippocampus [4]. Atypical AD phenotypes involve focal, primarily non-amnestic presenta-
tions, with symptoms that correlate with non-hippocampal tau pathology [5]. For example,
when logopenic Primary Progressive Aphasia (L-PPA) is caused by AD pathology, it begins
with word-finding difficulty at onset, with tau-related neurodegeneration prominent in lan-
guage associational cortex [6]. Posterior Cortical Atrophy (PCA) and “Dysexecutive” variants
of AD involve visual and dysexecutive symptoms at onset, with prominent neurodegeneration
found in visual and frontal association cortices, respectively [7–11]. Non-AD dementia syn-
dromes caused by frontotemporal lobar dementia (FTLD) pathology, including Semantic
Dementia (SD), behavioral variant FTD (bvFTD) and non-fluent/agrammatic Primary Pro-
gressive Aphasia (aPPA), also exhibit significant phenotypic heterogeneity [12].
The reasons why different brain networks are affected by dementia pathology in different
people are unclear. This is a critical research gap because a better understanding of the factors
that distinguishes atypical from typical phenotypes of dementia could lead to clues about the
primary pathogenesis of different forms of dementia, which remains unknown.
Specific LDs are common (i.e., 5–15% of children) and present early in life with difficulties
with word decoding / fluency, reading comprehension, spelling, writing, number sense or
mathematical reasoning, despite overall normal or high levels of intelligence [13]. Specific LDs
fall under the umbrella category of Neurodevelopmental Disorders in the new Diagnostic and
Statistical Manual of Mental Disorders Version 5 (DSM-5). Specific LDs should not be con-
fused with intellectual disability / intellectual development disorder, which is a separate diag-
nostic entity within Neurodevelopmental Disorders. Intellectual Disability has onset during the
childhood or adolescent years and includes both intellectual and adaptive functioning deficits
in conceptual, social and practical domains; these conditions are sometimes co-morbid with
LD [14]. By contrast, specific LD refers to handicaps that are not related to physical, develop-
mental or intellectual disabilities.
Three studies have suggested an association between LDs and specific dementia types [1–3].
The first study revealed that a PPA cohort reported increased family history of developmental
dyslexia but this cohort was not broken down into subtypes of PPA. The second study found that
the association was only present within the L-PPA subtype, which is L-PPA frequently associated
with underlying AD pathology [15, 16]. However, the autopsy follow-up of the patients from the
first study demonstrated that both AD and FTLD pathology was present in the PPA cohort
reporting family history of childhood LD [3]. It remains unknown whether adults with childhood
LD are in fact at increased risk of atypical phenotypes of dementia, and if so, which dementias.
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The objective of this clinic-based, pilot study was to further our understanding of the associ-
ation between self-reported LDs and three forms of atypical dementia that are often (though
not always) associated with underlying AD pathology (L-PPA, PCA, Dysexecutive AD). We
hypothesized that a higher proportion of individuals diagnosed with atypical dementias, vs.
Typical AD, would report a positive childhood history of LD. Both LDs and atypical dementias
are associated with atypical, long-range brain network topography [9, 17–20], providing a
potential common mechanism for LD and atypical dementia pathogenesis. Further evidence in
support of the hypothesis that developmental trajectories influence neurodegenerative pheno-
types includes several studies demonstrating childhood and adolescent brain differences in
people at genetic risk for Typical AD [21–26].
We built on the prior studies by grouping atypical dementia patients together who had a
high likelihood of underlying AD pathology, by considering personal, rather than family his-
tory, of childhood LD, and by adjusting for several potential confounders.
Ultimately, this line of research could identify a new risk factor for atypical dementia, which
might lead to clues about the cause of dementia or AD (which remains unknown) and to the
development of preventative interventions for atypical dementias, which remain unavailable.
Materials & Methods
The Columbia University Medical Center Internal Review Board approved this study. This
study was a retrospective chart review. All patient records/information was anonymized and
de-identified prior to analysis. As such, study participants were not required to provide
informed consent for their clinical records to be used in this study.
Initial Case Ascertainment
The authors reviewed consecutive neuropsychological reports of patients evaluated by three
neuropsychologists at the Columbia University Memory Disorders Clinic fromMarch 10th,
2011 through May 20th, 2014. Patients were referred from the Columbia University faculty
practice and New York State Psychiatric Institute Memory Disorders clinic. Consecutive
reports were reviewed in order to reduce selection bias.
Patients who were age 40 through 80 years at initial or follow-up evaluation by the neuro-
psychologist and suspected clinically by the neuropsychologist after complete neuropsycholog-
ical examination to have any diagnosis of Early Onset AD, Typical AD, Atypical Dementia of
any type (including PCA), PPA of any type, or behavioral variant FTD (bvFTD) were initially
selected. Age 80 was chosen as the cutoff to minimize recall bias and to maintain comparability
with the Atypical Dementia and FTLD patients. Patients who were born and raised outside the
United States were excluded because patients from countries in which diagnostic rates for chil-
dren with LDs lag behind the U.S. would be more likely to report negative history of childhood
LD and also because language barriers cause diagnostic challenge in atypical dementias.
Patients diagnosed with Dementia with Lewy Bodies, Parkinson’s Disease Dementia, another
movement disorder (Progressive Supranuclear Palsy, Corticobasilar Syndrome / Degeneration,
“Parkinson’s Plus”, motor neuron disease, normal pressure hydrocephalus) or with docu-
mented evidence of symptoms of a movement disorder were excluded because is actually a het-
erogeneous group of dementias that are difficult to diagnose accurately. We made further
exclusions if there was documented evidence of prior traumatic brain injury, major medical ill-
ness (e.g. cancer, heart surgery, traumatic brain injury, brain tumor, multiple sclerosis), and
stroke (as documented in past medical history by evaluating neuropsychologist).
Fig 1 summarizes how the final study sample was obtained. Of the initial 678 consecutive
neuropsychological evaluations, 217 were suspected by the neuropsychologist to have any type
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of neurodegenerative dementia, including AD, PPA, PCA or FTLD-related syndromes. Of
these, 112 cases were further excluded if both radiology and CSF data were unavailable or if
there was no neurology follow-up visit.
Subsequently, 105 cases diagnosed by the treating neuropsychologist with Late-onset Typi-
cal AD, Early-onset AD, Atypical AD (including PCA and Dysexecutive AD), PPA and FTLD-
related syndromes were subjected to a consensus diagnostic process. For late-onset AD
patients, consensus was considered present if the diagnosing neuropsychologist and the
Fig 1. Study Flow Chart with Inclusion and Exclusion Criteria. *e.g., cancer, heart surgery, traumatic brain injury, brain tumor, multiple sclerosis, stroke
(as documented by evaluating neuropsychologist). **e.g., myoclonus, dystonia, parkinsonism.
doi:10.1371/journal.pone.0129919.g001
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treating neurologist both documented a diagnosis of Typical, late-onset AD. For all other cases,
including early onset AD cases, two neuropsychologists and one neurologist specializing in
Aging & Dementia conferenced the patients one by one, using the appropriate published crite-
ria, as described below. During this process, the case reviewers were blinded to the Social &
Developmental History within the neuropsychological report, which contained information
about LDs. After consensus, 12 patients were further excluded because neuroimaging or CSF
was inconsistent with AD and also inconsistent with FTLD. 8 patients with bvFTD were
excluded to allow for a simple comparison between two groups (Atypical Dementia and Typi-
cal AD). 2 cases with non-fluent PPA were excluded because neuroimaging was inconclusive
(global hypoperfusion) and CSF was unavailable. The 85 remaining patients were grouped into
the comparison groups shown in Table 1.
Comparison Groups
The “Atypical Dementia” group included anyone with a consensus diagnosis of L-PPA, PCA,
or Dysexecutive AD. The Typical AD group included patients with consensus diagnosis of
Typical AD (with onset at any age).
Atypical Dementia. L-PPA was diagnosed using the clinical criteria by Gorno-Tempini,
et al [27]. These criteria allow for clinical, radiologically-confirmed, and pathologically-con-
firmed levels of classification. Patients without radiological or CSF supportive data were
excluded. Of note, up to 31% of patients with PPA of any type may not classify neatly into one
or another category [28]. In this study, we observed one instance in which a PPA patient simul-
taneously fulfilled clinical criteria for more than one type of PPA, but this patient was not
included in the final analysis due to lack of imaging or CSF data.
PCA was diagnosed if the patient presented with prominent, progressive visuospatial, visuo-
perceptual, literacy, or praxic skills, with radiological evidence of parietal, occipital, or occipito-
temporal cortices, relative sparing of the medial temporal cortex, and/or evidence of amyloid/
tau in the CSF. Diagnostic criteria for PCA are currently under development [29].
Dysexecutive AD was distinguished from Typical AD using a method previously described
which relies on neuropsychological test data [8, 30]. Specifically, patients who were initially
diagnosed by the neuropsychologist with AD with a dysexecutive or frontal presentation were
given a memory score (delayed recall subtracted from immediate recall in the logical memory
Table 1. Patient Characteristics at Baseline Neuropsychological Evaluation.
Characteristic Typical AD (n = 68) Atypical AD (n = 17) p-value
Age at evaluation, y, mean (SD) 70.1 (6.7) 67.1 (8.0) 0.17
Right Handedness, n (%) 62 (91%) 13 (77%) 0.09
Female, n (%) 37 (54%) 7 (41%) 0.32
Education, y, mean (SD)
College Education or higher, n (%) 43 (63%) 13 (77%) 0.30
Family Historya, n (%) 29 (43%) 6 (35%) 0.58
Probable LD, n (%) 6 (9%) 5 (29%) 0.02
Symptom durationb, y, mean (SD) 3.3 (2.3) 4.1 (2.0) 0.05
Supportive Data, n (%)
Neuroimaging 68 (100%) 17 (100%) —
CSF 8 (12%) 2 (12%) —
aFirst degree family member with any type of late-life cognitive impairment
bYears from first symptom onset to age at evaluation
doi:10.1371/journal.pone.0129919.t001
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test) and an executive score (Trail Making Test B minus Trail Making Test A). Z-scores were
calculated for executive and memory function. Participants with executive function scores at
least one standard deviation below memory scores were confirmed as belonging to the Dysexe-
cutive AD subgroup. If the patient was severely impaired in both, clinical history was used to
confirm that dysexecutive symptoms were most prominent at onset.
Reference ranges for CSF confirmation of AD pathology were as follows: 0–210 ng/l for tau
protein, 400–1200 pg/l for beta amyloid, 0–0.5 for tau/beta index. Imaging findings were con-
firmed using the written report by the radiologist and the documented interpretation by treat-
ing neurologist. Asymmetric temporoparietal atrophy or hypometabolism on structural or
functional neuroimaging, respectively, was considered as support for L-PPA. Predominant
frontotemporal atrophy, without significant parietal, temporal or occipital hypometabolism,
was considered as not consistent with L-PPA type, per the accepted criteria.
Typical AD. Typical AD was diagnosed using the NINCDS-ADRDA Criteria [31]. Pres-
ence of typicality of symptoms (primarily amnestic) was confirmed by methods previously
described to confirm the Dysexecutive subgroup. Supportive evidence of underlying AD
pathology was required for all cases (predominant temporo-parietal hypometabolism or atro-
phy) as documented either by the radiology report or the treating clinicians. Cases of early-
onset AD (defined as symptom onset prior to age 60) were included in the Typical AD group
because it was important to determine whether these cases belonged to Typical AD or Atypical
AD groups based on focality of presentation, irrespective of age.
Frontotemporal Lobar Degeneration Syndromes. Cases of bvFTD, aPPA, and SD were
initially identified and included in a group labeled “FTLD”. Although these can have differing
underlying pathologies, they all have in common non-AD related pathology in the vast major-
ity of cases [32]. Behavioral variant FTLD was diagnosed using criteria by Rascovsky et al [33].
Non-fluent/agrammatic PPA and Semantic Dementia were diagnosed using the criteria by
Gorno-Tempini, et al [27]. Due to low sample size, the FTLD group was not included in the
final analysis. The primary analysis was between Atypical Dementia group and Typical AD
group.
Childhood LD
The standard assessment by neuropsychologists for patients with dementia routinely includes
inquiry about history of childhood LDs. For this study, history of childhood LD was affirmed
using a consensus review of the Social & Developmental History (between two neuropsycholo-
gists). Self-reported LD was categorized as: Probable, Possible or Absent. Probable LD was
assigned if the patient reported previously being formally diagnosed or if there were two or
more documented statements in the Educational History supporting presence of LD. These
included: childhood need for special class, need for therapy, significant inattention or hyperac-
tivity, difficulty with reading, spelling, or letter direction, poor overall school performance, and
significant difficulty with math relative to reading. Possible LD was diagnosed if only one docu-
mented statement appeared in the history. Although no validated scale was used in this study,
many of these items are included in the Colorado Learning Difficulties Questionnaire, which
has been previously validated [34]. We categorized subjects as having language-related disabili-
ties (e.,g., reading, writing, speaking) or non-language-related disabilities (e.g., math, numbers)
but no specific diagnoses of LDs were made.
Co-Variates
Age of initial diagnosis and age of onset of first symptoms were obtained from the clinical eval-
uation at which the patient was first diagnosed. Level of education was ascertained by self-
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report and treated categorically in the final analysis (continuously in sensitivity analyses). First
degree family history of any type of cognitive impairment was also ascertained by self-report.
Cognitive impairment of any type was used as a surrogate for positive family history of demen-
tia. Ethnicity information was not recorded because it was not readily or accurately available
per the notes for many of the patients.
Data Analysis
85 patients were included in the final analysis (Typical AD n = 68, Atypical Dementia n = 17).
All comparisons, including the primary analysis, were made between the Typical AD and
Atypical Dementia group. Chi-squared tests were used to compare categorical variables (hand-
edness, gender, college degree, first degree family history) and t-tests were used to compare
continuous variables (age, symptom duration).
In the primary analysis, we performed a logistic regression with Atypical Dementia vs. Typi-
cal AD, as the outcome, and Probable LD vs. Absent or Possible LD, as the primary predictor
(Model 1). Model 2 was further adjusted for age, gender, education (college degree or higher),
and handedness. To account for disease stage, Model 3 was further adjusted for symptom dura-
tion. Symptom duration was used as a proxy for disease stage because the use of cognitive test
scores or CDR scores would have created difficultly considering that minor language or vision
disturbances in Atypical Dementia can cause disproportionately lower scores on cognitive or
functional tests.
We also investigated whether first degree family history of cognitive impairment or demen-
tia of any kind influenced this association by performing separate analyses in patients with and
without family history. Finally, we explored qualitatively whether the type of LD (language vs.
non-language) segregated with the type of Atypical Dementia and explored whether early-
onset AD cases differed in frequency of self-reported LD from the other group. To ensure
validity of findings given sample size, we calculated Nagelkerke and Cox & Snell coefficients
and Chi-square values of significance for each model. We also conducted bootstrap analyses to
address small sample size and to confirm the validity of the findings. Our bootstrapping sam-
pling method was at 90% resampling at each iteration. Data were analyzed using IBM SPSS ver-
sion 21.
Results
85 patients were included in the final analysis (Typical AD, n = 68, Atypical Dementia, n = 17).
The 17 cases of Atypical Dementia included 11 L-PPA patients, 3 PCA patients and 3 Dysexe-
cutive AD patients. Overall, there were no significant differences in age at evaluation, symptom
duration, handedness, sex, and educational levels between the Atypical Dementia group and
Typical AD group, although there was a trend towards higher percentage of left-handedness
and longer symptom duration prior to diagnosis in the Atypical Dementia group. Structural or
functional imaging was available for 100% of Typical AD and 100% of Atypical Dementia
cases; CSF was available for 12% of Typical AD and 12% of Atypical Dementia cases. In both
cases of L-PPA who underwent CSF testing, CSF was positive for AD biomarkers. All 11 cases
of L-PPA had radiology testing consistent with Probable L-PPA subtype.
In logistic regression models fully adjusted for age at evaluation, sex, handedness, education
and symptom duration (see Table 2), patients with Probable LD, compared to a combined
group of patients with Possible or Absent LD, were significantly more likely to be diagnosed
with Atypical Dementia vs. Typical AD (OR 13.1, 95% CI 1.3–128.4). Four subjects reported
Possible LD and were included in the Possible/Absent group. In qualitative observations
regarding type of LD, we noted that of the three L-PPA cases with Probable LD, all three
Learning Disabilities and Atypical Dementia
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involved language difficulty. By contrast, both PCA cases reporting Probable childhood LD
endorsed difficulty with attention and math (as did another PCA case with Possible LD, see
Table 3). There were no apparent interactions with self-reported family history of dementia.
In sensitivity analyses, when we considered Possible and Probable LD together (vs. Probable
LD only), and when we treated education as a categorical or continuous variable, results were
unchanged. When we included subjective report of first degree family history of any cognitive
impairment in the model as a co-variate rather than as an interaction term, results did not
change. Statistical tests performed due to small sample sizes confirmed the validity of these
findings. For each model, correlation coefficients for exact tests were small, indicating low
degree of inter-variable correlation. For each model, the bootstrapped confidence intervals
were more narrow and retained significance (CI 0.2 to 22.3). To identify why the OR changed
fromModel 1 to Model 2, we used step-wise analyses which identified that addition of the edu-
cation variable (College or Higher vs. Less than College) to the model was responsible for this
change.
Discussion
In this clinic-based study of 85 patients with consensus diagnoses of Atypical Dementia or
Typical AD supported by radiological or CSF data, patients who presented for neuropsycholog-
ical evaluation who also reported positive childhood history of LD were more likely to be diag-
nosed with Atypical Dementia vs. Typical AD, compared with subjects reporting no childhood
history of LD. Results remained significant after adjusting for age, sex, handedness, education
and symptom duration. Qualitative observation revealed that the three subjects reporting a his-
tory of LD in the L-PPA group endorsed difficulty with language while both subjects reporting
an LD history in the PCA group described difficulty with attention and/or numbers, support-
ing the notion that childhood cognitive phenotypes may predict phenotypic patterns of neuro-
degenerative disease.
The present study confirms and contributes to the three prior studies on this subject. In a
study of over 600 patients from the Northwestern Alzheimer’s Disease Center registry, 16% of
108 individuals with PPA (of any type) and 32% of their first degree family members answered
affirmatively to having a history of LD [1]. These frequencies were significantly higher than
those noted in control patients without AD, patients with typical amnestic AD, and patients
with behavioral variant FTLD. Among the families of PPA probands, clusters of LDs, particu-
larly developmental dyslexia, were noted. A second study utlized a more specific breakdown of
the type of PPA, with imaging-supported classification [2]. Specifically, 8% of all PPA patients
from the University of California San Francisco Memory and Aging Center had self- or infor-
mant-based report personal history of delay in speaking or reading at baseline medical inter-
view. This finding was driven by a particularly high percentage (25%) in the 48 patients with
L-PPA. Radiologic data in, L-PPA patients with LD was notable for atrophy in the same areas









Absent or Possible LD — — —
Probable LD 4.3 (1.1–16.4) 13.7 (1.4–134.5) 13.1 (1.3–128.4)
aUnadjusted
bAdjusted for Age at Evaluation, Gender, Handedness and Education
cAdditionally adjusted for symptom duration
doi:10.1371/journal.pone.0129919.t002
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affected as those in developmental dyslexia (posterior middle and superior temporal gyri). The
clinical specificity of LD to L-PPA may indicate an association with AD pathology. Another
group which studied a cohort of individuals with PPA of any type found both AD and FTLD
pathology, suggesting that any specific association with LD may only have relevance in predict-
ing clinical phenotype but not necessarily underlying pathology [3]. In our study, 0/8 behav-
ioral variant FTLD patients reported Probable LD. Due to low sample size, there were no aPPA
or SD cases which made the final analysis, so we were unable to assess whether the association
between LD and PPA is specific to L-PPA type, which remains to be further studied [2]. Our
study is the first to suggest that Posterior Cortical Atrophy may be related to developmental
non-language LD’s (i.e., dyscalculia).
Impaired connectivity within a specific brain region, from genetic or acquired causes, could
represent the shared pathological mechanism linking LDs to Atypical AD or other dementias.
This hypothesis is sometimes referred to as “selective vulnerability”. Fig 2 presents a simplified
model of this conceptual framework. Region-specific connectivity differences associated with
LDs [20] could predispose to neuronal failure in the face of amyloidosis or other dementia risk
factors, thus commencing the neurodegenerative pathophysiological cascade. Connectivity can
be impaired at the synaptic, dendritic, axonal or neuronal level. In fact, recent evidence may
support the notion that disruptions at the synaptic level by soluble amyloid represent primary
events in AD neurodegeneration [35, 36]. Trophic disconnections may be central to neurode-
generation due to AD [20][37, 38].
The conflicting findings regarding whether developmental dyslexia is associated specifically
with L-PPA, and not other subtypes of PPA, are especially important because logopenic-type
PPA is frequently associated with underlying AD pathology [15, 16]. This implies that the rela-
tionship between LDs and dementia could be specific to AD. AD, unlike other dementias, is
thought to begin specifically within associational cortex of the brain; tau-related neurodegen-
eration in AD selectively affects long, projection neurons which connect higher association
Table 3. Characterization of subjects with Possible or Probable LD.
Gender Hand Preference LD Type Age of onset First symptom Consensus Diagnosisa
Probable LD:
Female Right Dyslexia / ADHD 55 Mixed Typical AD
Female Right Dyslexia / ADHD 66 Memory Typical AD
Male Right Dyslexia 70 Judgment/problem solving Typical AD
Male Right Dyslexia 67 Attention Typical AD
Male Right ADHD 61 Memory Typical AD
Male Right Dyslexia 53 Mixed Typical AD
Female Left Dyslexia 48 Language L-PPA
Male Left Dyslexia 67 Language L-PPA
Male Right Stuttering 61 Language L-PPA
Female Right ADHD 67 Mixed PCA
Male Right Dyscalculia 62 Visuospatial PCA
Possible LD:
Female Right Dyslexia 73 Memory Typical AD
Male Right Stuttering 72 Memory Typical AD
Male Right ADHD 49 Behavioral Dysexecutive AD
Female Right Dyscalculia 64 Attention PCA
aL-PPA = logopenic-type Primary Progressive Aphasia; PCA = Posterior Cortical Atrophy
doi:10.1371/journal.pone.0129919.t003
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cortex with other brain regions [3]. Developmental LDs are also characterized pathologically
by impairments in long-range brain network connections and differences in left-right white
matter dominance. If some cases of Atypical AD represent downstream extensions of LD, then
Typical AD might also represent a direct extension of a neurodevelopmental phenotype. In
fact, the literature on Typical AD and neurodevelopment supports this. In Typical AD, the lat-
eral entorhinal cortex, precuneus and posterior cingulate gyrus appear the most vulnerable to
neurodegeneration. During typical neurodevelopment, these areas are the last to myelinate and
the most poorly myelinated [4]. Differences in white matter connectivity, mitochondrial activ-
ity and gray matter volume in these regions have been demonstrated in infants, children, ado-
lescents and non-demented persons at genetic risk for Typical AD (due to APOE4 or SORL1
variants) [21–26]. Also, proteins involved in AD-related neurodegeneration function in a vari-
ety of neurodevelopmental processes [39, 40]. With this in mind, genes found to be associated
with LDs should continue to be investigated as candidate genes for Atypical AD or other
dementias [41, 42].
Small sample size, selection bias, poor measurement of the primary risk factor (LD), and
suboptimal accounting of disease severity, among other limitations to this study, could have
negatively influenced the results. The authors carefully discussed these potential limitations
prior to selection of the final study design. Only 85 of 678 patients (14%) were included in the
final analysis. Small sample size could have introduced error into the analysis. Nonetheless, the
large effect sizes observed, the retained significance in bootstrapped analyses, as well as the
retained significance across other sensitivity analyses, would suggest that the finding is in fact
not spurious. In addition, using exact tests, we demonstrated that there was not high inter-cor-
relation of the variables, which also supports the validity of the study in the context of small
sample size. Sensitivity analyses also revealed that the small sample size and unequal distribu-
tion of education could have explained the change in OR fromModel 1 to Model 2 (we did not
have years of education, in a continuous variable, available for analysis.) Regarding selection
bias, exclusion of patients with non-neurodegenerative dementias, such as those with migraine
Fig 2. Conceptual Map of Pathological Links Between Developmental Learning Disabilities and Region-Specific Neurodegeneration. In the model
shown above, atypical connectivity associated with learning disabilities, in the presence of aging and other dementia risk factors, serves as the primary
impetus for metabolic failure in the related brain network, which subsequently leads to region-specific neurodegenerative pathology.
doi:10.1371/journal.pone.0129919.g002
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or psychiatric illness, was not expected to cause bias in one direction or another. In fact, conse-
cutive review of all cases was done specifically to mimimize selection bias. Another major limi-
tation of this study involved the collection of the data on childhood history of LD. With only
retrospective data, we relied on self-report of LDs and the style of elicitation of information
about LDs varied by neuropsychologist. We could not objectively confirm presence or absence
of LD using neuropsychological data because patients were already demented. Additionally,
patients with a diagnosis of Atypical AD may have been more likely to answer affirmatively to
questions about history of LDs because they were seeking an explanation for their unique
symptoms. According to this logic, patients with early onset AD and FTLD would also be
expected to answer affirmatively but we did not note increased frequency of LDs in these
groups (1/10 patients with early-onset AD reported probable LD). Other limitations included
reliance on symptom duration as a proxy for disease severity and being unable to account for
severity of LD. Severity of underlying AD or LD pathology could influence the relationship
between LD and AD phenotype. Additionally, we could not accurately collect information on
ethnicity. Ethnicity is an important potential confounder because diagnostic rates of LDs and
of AD vary by ethnicity. A related limitation was that our final sample was demographically
homogenous, limiting the generalizability of our findings. Lastly, while we were able to draw
conclusions about Atypical Dementia as a whole, this study was underpowered to evaluate sub-
types of Atypical Dementia and to draw direct conclusions about the association between LDs,
AD and FTLD.
Despite the limitations, the paper has several strengths. One important strength of this study
was the availability of structural or functional imaging for all cases where available to ensure, to
the best of our abilities, little to no pathological overlap between groups. We limited the study to
patients with supportive data because significant discordance exists between clinical phenotypes
of dementia and underlying cellular pathology. The clinical classifications for PPA, for example,
require further refinement, as patients can sometimes fulfill more than one or neither clinical
diagnostic classification for PPA [43]. We grouped the patients such that patients included in
the Atypical Dementia group were likely (to the extent possible) to have underlying AD pathol-
ogy as a common factor. We attempted, in essence, to create a group of Atypical AD patients.
By doing this, we found a 30% frequency of self-reported LD, which is consistent with the 25%
frequency of self-reported learning disabilities in patients with L-PPA. None of the patients in
our L-PPA group had frontotemporal hypometabolism on functional imaging, and all had tem-
poroparietal metabolism, which is much more strongly associated with AD pathology. Another
important strength includes the fact that we adjusted for several potential confounders.
Conclusions
During the initial neuropsychological evaluation, patients diagnosed with Atypical Dementias
(i.e., L-PPA, PCA, or Dysexecutive AD) endorse symptoms of previous childhood LD at a
higher rate than patients diagnosed with Typical AD. Specifically, some patients with PPA
endorse childhood symptoms of language difficulty and some patients with PCA endorse
childhood symptoms of math and/or attention difficulty. In the near term, studies are required
to confirm these findings using more accurate measurement of childhood LD and patholog-
ically-confirmed diagnoses of neurodegenerative disease. If the association between LD and
Atypical Dementia is confirmed, future longitudinal studies will be required to identify
whether there is underlying common pathology between LD and dementia related to network
connectivity. Future research is also needed in order to determine the probable genetic and/or
modifying factors (and the underlying mechanisms) that predispose some, but not all people,
with atypical neurodevelopment, to develop atypical neurodegenerative disease.
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